Answer the following items using your own words, be objective and concise while being professional
1. During case presentation at your clinic, you are reviewing four women with predisposing factors for osteoporosis. Which patient is least likely to be at risk for osteoporosis?
A. Nehineza, an overweight African American female with family history of uterine cancer B. Cristina, a Hispanic woman living a sedentary life
C. Park-Gim-Ka, an underweight Asian woman with a history of tobacco use
D. Skylar, a Caucasian woman experiencing early onset of menopause.
2. Densitometry results are given as T-scores, which values would be considered as osteopenia?
3. After prompt analysis of your patient, you decide to institute treatment for osteoporosis. Which class medication is considered as the first-line treatment? Are there any considerations to be taken prior starting therapy? Which recommendations would you provide to the patient regarding this treatment?
2 PAGES
NO MORE THAN 10% PLAGIO ALLOW
DUE DATE JULY 2, 2024 NO LATER
Answer the following items using your own words, be objective and concise while being professional
1. During case presentation at your clinic, you are reviewing four women with predisposing factors for osteoporosis. Which patient is least likely to be at risk for osteoporosis?
A. Nehineza, an overweight African American female with family history of uterine cancer B. Cristina, a Hispanic woman living a sedentary life
C. Park-Gim-Ka, an underweight Asian woman with a history of tobacco use
D. Skylar, a Caucasian woman experiencing early onset of menopause.
2. Densitometry results are given as T-scores which values would be considered as osteopenia?
3. After prompt analysis of your patient, you decide to institute treatment for osteoporosis. Which class medication is considered as the first-line treatment? Are there any considerations to be taken prior starting therapy? Which recommendations would you provide to the patient regarding this treatment?
2 PAGES
NO MORE THAN 10% PLAGIO ALLOW
DUE DATE JULY 2, 2024 NO LATER